186 related articles for article (PubMed ID: 6987607)
1. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
Grim CE; Weinberger MH
Pediatrics; 1980 Mar; 65(3):597-604. PubMed ID: 6987607
[TBL] [Abstract][Full Text] [Related]
2. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
[TBL] [Abstract][Full Text] [Related]
4. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Kramer NJ; Lerman R; Furuyama S; Nugent CA
J Clin Invest; 1973 Sep; 52(9):2272-7. PubMed ID: 4353776
[TBL] [Abstract][Full Text] [Related]
5. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.
Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD
J Hypertens; 1995 Dec; 13(12 Pt 2):1610-3. PubMed ID: 8903619
[TBL] [Abstract][Full Text] [Related]
6. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
Stockigt JR; Scoggins BA
J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis.
Lee SM; Lightner E; Witte M; Oberfield S; Levine L; New MI
Acta Endocrinol (Copenh); 1982 Feb; 99(2):251-5. PubMed ID: 6277130
[TBL] [Abstract][Full Text] [Related]
8. Normotensive glucocorticoid-suppressible hyperaldosteronism in adult.
Maeda T; Ashie T; Kikuiri K; Takakura M; Hikita N; Nakagawa H; Shimamoto K
Endocrinol Jpn; 1989 Dec; 36(6):817-25. PubMed ID: 2633910
[TBL] [Abstract][Full Text] [Related]
9. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
Skrabal F; Mauser R
Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
[TBL] [Abstract][Full Text] [Related]
10. Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I.
Stowasser M; Huggard PR; Rossetti TR; Bachmann AW; Gordon RD
J Clin Endocrinol Metab; 1999 Nov; 84(11):4031-6. PubMed ID: 10566645
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone-suppressible hyperaldosteronism: a large new kindred.
O'Mahony S; Burns A; Murnaghan DJ
J Hum Hypertens; 1989 Aug; 3(4):255-8. PubMed ID: 2552113
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia?
Connell JM; Kenyon CJ; Corrie JE; Fraser R; Watt R; Lever AF
Hypertension; 1986 Aug; 8(8):669-76. PubMed ID: 3015796
[TBL] [Abstract][Full Text] [Related]
13. Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism.
Woodland E; Tunny TJ; Hamlet SM; Gordon RD
Clin Exp Pharmacol Physiol; 1985; 12(3):245-8. PubMed ID: 2992855
[TBL] [Abstract][Full Text] [Related]
14. A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II.
Fallo F; Sonino N; Armanini D; Luzzi T; Pedini F; Pasini C; Mantero F
Clin Endocrinol (Oxf); 1985 Jun; 22(6):777-85. PubMed ID: 2990765
[TBL] [Abstract][Full Text] [Related]
15. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
Hood SJ; Taylor KP; Ashby MJ; Brown MJ
Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
[TBL] [Abstract][Full Text] [Related]
16. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone suppressible hyperaldosteronism: insights into adrenal physiology.
Connell JM; Jardine A; Fraser R
Adv Nephrol Necker Hosp; 1990; 19():69-77. PubMed ID: 2154082
[No Abstract] [Full Text] [Related]
18. A German family with glucocorticoid-remediable aldosteronism.
Vonend O; Altenhenne C; Büchner NJ; Dekomien G; Maser-Gluth C; Weiner SM; Sellin L; Hofebauer S; Epplen JT; Rump LC
Nephrol Dial Transplant; 2007 Apr; 22(4):1123-30. PubMed ID: 17277347
[TBL] [Abstract][Full Text] [Related]
19. [Hypertension treatable with glucocorticoids: report of a case].
Montero J; Fardella C; Mosso L
Rev Med Chil; 1997 Nov; 125(11):1361-5. PubMed ID: 9609059
[TBL] [Abstract][Full Text] [Related]
20. Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism.
Gill JR; Bartter FC
J Clin Endocrinol Metab; 1981 Aug; 53(2):331-7. PubMed ID: 6265487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
